TY - JOUR
T1 - Rationale and design of the health economics evaluation registry for remote follow-up
T2 - TARIFF
AU - Ricci, Renato P.
AU - D'Onofrio, Antonio
AU - Padeletti, Luigi
AU - Sagone, Antonio
AU - Vicentini, Alfredo
AU - Vincenti, Antonio
AU - Morichelli, Loredana
AU - Cavallaro, Ciro
AU - Ricciardi, Giuseppe
AU - Lombardi, Leonida
AU - Fusco, Antonio
AU - Rovaris, Giovanni
AU - Silvestri, Paolo
AU - Guidotto, Tiziana
AU - Pollastrelli, Annalisa
AU - Santini, Massimo
PY - 2012/11
Y1 - 2012/11
N2 - AimsThe aims of the study are to develop a cost-minimization analysis from the hospital perspective and a cost-effectiveness analysis from the third payer standpoint, based on direct estimates of costs and QOL associated with remote follow-ups, using Merlinhome and Merlin.net, compared with standard ambulatory follow-ups, in the management of ICD and CRT-D recipients.Methods and resultsRemote monitoring systems can replace ambulatory follow-ups, sparing human and economic resources, and increasing patient safety. TARIFF is a prospective, controlled, observational study aimed at measuring the direct and indirect costs and quality of life (QOL) of all participants by a 1-year economic evaluation. A detailed set of hospitalized and ambulatory healthcare costs and losses of productivity that could be directly influenced by the different means of follow-ups will be collected. The study consists of two phases, each including 100 patients, to measure the economic resources consumed during the first phase, associated with standard ambulatory follow-ups, vs. the second phase, associated with remote follow-ups.ConclusionRemote monitoring systems enable caregivers to better ensure patient safety and the healthcare to limit costs. TARIFF will allow defining the economic value of remote ICD follow-ups for Italian hospitals, third payers, and patients. The TARIFF study, based on a cost-minimization analysis, directly comparing remote follow-up with standard ambulatory visits, will validate the cost effectiveness of the Merlin.net technology, and define a proper reimbursement schedule applicable for the Italian healthcare system.Trial registration: NCT01075516.
AB - AimsThe aims of the study are to develop a cost-minimization analysis from the hospital perspective and a cost-effectiveness analysis from the third payer standpoint, based on direct estimates of costs and QOL associated with remote follow-ups, using Merlinhome and Merlin.net, compared with standard ambulatory follow-ups, in the management of ICD and CRT-D recipients.Methods and resultsRemote monitoring systems can replace ambulatory follow-ups, sparing human and economic resources, and increasing patient safety. TARIFF is a prospective, controlled, observational study aimed at measuring the direct and indirect costs and quality of life (QOL) of all participants by a 1-year economic evaluation. A detailed set of hospitalized and ambulatory healthcare costs and losses of productivity that could be directly influenced by the different means of follow-ups will be collected. The study consists of two phases, each including 100 patients, to measure the economic resources consumed during the first phase, associated with standard ambulatory follow-ups, vs. the second phase, associated with remote follow-ups.ConclusionRemote monitoring systems enable caregivers to better ensure patient safety and the healthcare to limit costs. TARIFF will allow defining the economic value of remote ICD follow-ups for Italian hospitals, third payers, and patients. The TARIFF study, based on a cost-minimization analysis, directly comparing remote follow-up with standard ambulatory visits, will validate the cost effectiveness of the Merlin.net technology, and define a proper reimbursement schedule applicable for the Italian healthcare system.Trial registration: NCT01075516.
KW - Cardiac resynchronization therapy
KW - Implantable cardioverter defibrillator
KW - Remote monitoring
KW - Telemedicine
KW - Telemonitoring
UR - http://www.scopus.com/inward/record.url?scp=84868529547&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84868529547&partnerID=8YFLogxK
U2 - 10.1093/europace/eus093
DO - 10.1093/europace/eus093
M3 - Article
C2 - 22544910
AN - SCOPUS:84868529547
VL - 14
SP - 1661
EP - 1665
JO - Europace
JF - Europace
SN - 1099-5129
IS - 11
ER -